Anna Hoy

Associate Director, Pre-clinical Development, Resolution Therapeutics

Anna Hoy is Associate Director of Nonclinical Development at Resolution Therapeutics, a biotech that originated in Edinburgh and is pioneering cell therapies for inflammatory and fibrotic disease. She leads delivery of nonclinical strategy across RTx’s pipeline, including the lead programme, RTX001, in end-stage liver disease.

Events Anna Hoy has spoken at

Cell 2026 12 November 2026 – 13 November 2026